Effects of Gadodiamide and Gadoteric Acid on Rat Kidneys: A Comparative Study. Issue 2 (13th September 2018)
- Record Type:
- Journal Article
- Title:
- Effects of Gadodiamide and Gadoteric Acid on Rat Kidneys: A Comparative Study. Issue 2 (13th September 2018)
- Main Title:
- Effects of Gadodiamide and Gadoteric Acid on Rat Kidneys: A Comparative Study
- Authors:
- Celiker, Fatma Beyazal
Tumkaya, Levent
Mercantepe, Tolga
Beyazal, Mehmet
Turan, Arzu
Beyazal Polat, Hatice
Suzan, Zehra Topal
Inecikli, Mehmet Fatih
Akyildiz, Kerimali
Yilmaz, Adnan - Abstract:
- Abstract : Background: Gadolinium‐based contrast agents are complex chelates to provide contrast in NRI. However, recent studies have highlighted the deposition of free Gd +3 ion in various tissues. Purpose: To evaluate the histopathological and immunohistochemical changes on rat kidney tissue following both macrocyclic (gadoteric acid) and linear (gadodiamide) agents under the hypothesis that gadolinium‐based contrast agents (GBCA) lead to toxic, free Gd +3 accumulation in tissues. Study Type: The local Animal Care Committee approved the prospective animal study. Animal Model: Thirty‐two healthy Sprague–Dawley male rats were administered 2 mmol/kg gadodiamide and gadoteric acid for the first 4 days for 5 weeks. Group 1 received no drug (control, n = 8) and Group 2 ( n = 8) was administered 0.1 ml/kg saline. Group 3 was administered 0.1 mmol/kg gadodiamide and Group 4 ( n = 8) was administered 2 mmol/kg gadoteric acid. Assessment: Biochemical, histopathological, and immunohistochemical changes in testis kidney tissue were evaluated at the end of 10 weeks. Statistical Tests: Differences between groups were analyzed using the nonparametric Kruskal–Wallis test followed by one‐way analysis of variance and the Tamhane test, also followed by Turkey's HSD test. Results: Gadolinium increased serum urea, Ca +2, and Caspase‐3 positive tubular cell number. Larger Bowman capsules shrank proximal and distal tubules were revealed in the gadodiamide and gadoteric acid groups compared toAbstract : Background: Gadolinium‐based contrast agents are complex chelates to provide contrast in NRI. However, recent studies have highlighted the deposition of free Gd +3 ion in various tissues. Purpose: To evaluate the histopathological and immunohistochemical changes on rat kidney tissue following both macrocyclic (gadoteric acid) and linear (gadodiamide) agents under the hypothesis that gadolinium‐based contrast agents (GBCA) lead to toxic, free Gd +3 accumulation in tissues. Study Type: The local Animal Care Committee approved the prospective animal study. Animal Model: Thirty‐two healthy Sprague–Dawley male rats were administered 2 mmol/kg gadodiamide and gadoteric acid for the first 4 days for 5 weeks. Group 1 received no drug (control, n = 8) and Group 2 ( n = 8) was administered 0.1 ml/kg saline. Group 3 was administered 0.1 mmol/kg gadodiamide and Group 4 ( n = 8) was administered 2 mmol/kg gadoteric acid. Assessment: Biochemical, histopathological, and immunohistochemical changes in testis kidney tissue were evaluated at the end of 10 weeks. Statistical Tests: Differences between groups were analyzed using the nonparametric Kruskal–Wallis test followed by one‐way analysis of variance and the Tamhane test, also followed by Turkey's HSD test. Results: Gadolinium increased serum urea, Ca +2, and Caspase‐3 positive tubular cell number. Larger Bowman capsules shrank proximal and distal tubules were revealed in the gadodiamide and gadoteric acid groups compared to the control group ( P < 0.05). Histopathologic examination showed significantly more interstitial fibrosis, amyloid deposits, and vasocongestion in the gadodiamide group than the gadoteric acid and control groups, while the gadoteric acid group demonstrated significantly more leukocytic infiltration with atrophied proximal and distal tubules than the gadodiamide and control groups ( P < 0.05). Data Conclusion: GBCA administration causes significant histopathologic changes in kidney tissue. This study advocates additional investigation to assess the in vivo safety of GBCAs. Level of Evidence : 1 Technical Efficacy : Stage 2 J. Magn. Reson. Imaging 2019;49:382–389. … (more)
- Is Part Of:
- Journal of magnetic resonance imaging. Volume 49:Issue 2(2019)
- Journal:
- Journal of magnetic resonance imaging
- Issue:
- Volume 49:Issue 2(2019)
- Issue Display:
- Volume 49, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 49
- Issue:
- 2
- Issue Sort Value:
- 2019-0049-0002-0000
- Page Start:
- 382
- Page End:
- 389
- Publication Date:
- 2018-09-13
- Subjects:
- contrast material -- gadolinium -- kidney -- magnetic resonance imaging -- rat
Magnetic resonance imaging -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1522-2586 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jmri.26266 ↗
- Languages:
- English
- ISSNs:
- 1053-1807
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5010.791000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9413.xml